Nomura Holdings’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$778K Buy
+5,700
New +$700K ﹤0.01% 1426
2025
Q1
– Sell
-54,400
Closed -$7.83M – 2282
2024
Q4
$7.83M Buy
+54,400
New +$7.8M 0.01% 604
2022
Q4
– Sell
-16,100
Closed -$3.02M – 1673
2022
Q3
$3.02M Buy
+16,100
New +$3.39M 0.01% 710
2021
Q4
– Sell
-26,900
Closed -$7.57M – 2431
2021
Q3
$7.57M Sell
26,900
-45,900
-63% -$11.8M 0.02% 493
2021
Q2
$14.6M Buy
+72,800
New +$14.1M 0.04% 279

Other funds holding RGEN

Nomura Holdings's RGEN Position: Q3 2024 in Review

Nomura Holdings sold out of Repligen (RGEN) in Q3 2024, closing a stake of 17,601 shares — an estimated $2.22M sold.

Nomura Holdings first reported a position in RGEN in Q4 2014 and held it in 6 quarters. The position peaked at $3.97M in Q1 2021. 444 funds tracked by Wall St. Rank hold RGEN as of Q3 2024.

  • Nomura Holdings reported no remaining Repligen position as of Q3 2024 after selling out during the quarter.
  • Nomura Holdings sold 17,601 Repligen shares in Q3 2024, an estimated $2.22M.
  • Nomura Holdings first reported a position in Repligen in Q4 2014 and held it in 6 quarters.
  • Nomura Holdings's Repligen position peaked at $3.97M in Q1 2021.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q3 2024.

Based on Nomura Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.